Is Mirum Pharmaceuticals, Inc. (MIRM) a Buy, Sell, or Hold?
NASDAQ : MIRM
Mirum Pharmaceuticals, Inc. — Analyst Ratings
$109.43 USD
-$2.8 (-2.49%)
- Volume
- 305.91K
- Average Volume
- 1M
- Market Capitalization
- $6.67B
- P/E Ratio
- -8.04
- Dividend Yield
- 0.00%
- Price Target
- $145.50
- Year High
- $130.00
- Year Low
- $50.25
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.09
Analyst Consensus Summary
Consensus Rating
Strong Sell
18 Analysts
Rating Score
1/5
Recommendation Strength
Upside/Downside
-24.8%
vs Current Price
Price Target
$145.50
Average TargetPrice Target Range
Lowest Target
$118.00
-7.3% DOWNSIDE
Average Target
$145.50
Median Estimate
Highest Target
$185.00
-40.8% DOWNSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 18
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 1 | 17 | 0 | 0 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| RBC Capital | Lisa Walter | $148 | $121.91 | 2026-07-07 07:31 AM | 21.4% |
| RBC Capital | Joe Kim | $142 | $104.8299 | 2026-05-07 09:32 AM | 35.5% |
| Raymond James | Ryan Deschner | $165 | $100.922 | 2026-05-07 08:41 AM | 63.5% |